| Enhanced drug delivery by dissolution of amorphous drug encapsulated in a water unstable metal–organic framework (MOF) K Suresh, AJ Matzger Angewandte Chemie International Edition 58 (47), 16790-16794, 2019 | 248 | 2019 |
| Novel furosemide cocrystals and selection of high solubility drug forms NR Goud, S Gangavaram, K Suresh, S Pal, SG Manjunatha, S Nambiar, ... Journal of pharmaceutical sciences 101 (2), 664-680, 2012 | 180 | 2012 |
| Fast dissolving eutectic compositions of curcumin NR Goud, K Suresh, P Sanphui, A Nangia International journal of pharmaceutics 439 (1-2), 63-72, 2012 | 135 | 2012 |
| Curcumin: Pharmaceutical solids as a platform to improve solubility and bioavailability K Suresh, A Nangia CrystEngComm 20 (24), 3277-3296, 2018 | 110 | 2018 |
| Optimizing hydrogen storage in MOFs through engineering of crystal morphology and control of crystal size K Suresh, D Aulakh, J Purewal, DJ Siegel, M Veenstra, AJ Matzger Journal of the American Chemical Society 143 (28), 10727-10734, 2021 | 108 | 2021 |
| A novel curcumin–artemisinin coamorphous solid: physical properties and pharmacokinetic profile K Suresh, MKC Mannava, A Nangia Rsc Advances 4 (102), 58357-58361, 2014 | 81 | 2014 |
| Novel synthons in sulfamethizole cocrystals: structure–property relations and solubility K Suresh, VS Minkov, KK Namila, E Derevyannikova, E Losev, A Nangia, ... Crystal Growth & Design 15 (7), 3498-3510, 2015 | 66 | 2015 |
| Entacapone: Improving aqueous solubility, diffusion permeability, and cocrystal stability with theophylline MK Bommaka, MKC Mannava, K Suresh, A Gunnam, A Nangia Crystal Growth & Design 18 (10), 6061-6069, 2018 | 63 | 2018 |
| Andrographolide: solving chemical instability and poor solubility by means of cocrystals K Suresh, NR Goud, A Nangia Chemistry–An Asian Journal 8 (12), 3032-3041, 2013 | 60 | 2013 |
| Enhanced bioavailability in the oxalate salt of the anti-tuberculosis drug ethionamide MKC Mannava, K Suresh, A Nangia Crystal Growth & Design 16 (3), 1591-1598, 2016 | 55 | 2016 |
| Cocrystals and alloys of nitazoxanide: enhanced pharmacokinetics K Suresh, MKC Mannava, A Nangia Chemical communications 52 (22), 4223-4226, 2016 | 52 | 2016 |
| Lornoxicam salts: crystal structures, conformations, and solubility K Suresh, A Nangia Crystal growth & design 14 (6), 2945-2953, 2014 | 46 | 2014 |
| A furosemide–isonicotinamide cocrystal: an investigation of properties and extensive structural disorder HE Kerr, LK Softley, K Suresh, A Nangia, P Hodgkinson, IR Evans CrystEngComm 17 (35), 6707-6715, 2015 | 45 | 2015 |
| Solubility and stability advantage of aceclofenac salts NR Goud, K Suresh, A Nangia Crystal growth & design 13 (4), 1590-1601, 2013 | 44 | 2013 |
| Salts and salt cocrystals of the antibacterial drug pefloxacin A Gunnam, K Suresh, A Nangia Crystal Growth & Design 18 (5), 2824-2835, 2018 | 40 | 2018 |
| Structure and physicochemical characterization of a naproxen–picolinamide cocrystal HE Kerr, LK Softley, K Suresh, P Hodgkinson, IR Evans Acta Crystallographica Section C: Structural Chemistry 73 (3), 168-175, 2017 | 37 | 2017 |
| Curcumin-artemisinin coamorphous solid: Xenograft model preclinical study MKC Mannava, K Suresh, M Kumar Bommaka, D Bhavani Konga, ... Pharmaceutics 10 (1), 7, 2018 | 35 | 2018 |
| Crystal engineering of a zwitterionic drug to neutral cocrystals: a general solution for floxacins A Gunnam, K Suresh, R Ganduri, A Nangia Chemical communications 52 (85), 12610-12613, 2016 | 34 | 2016 |
| Metal‐Organic Framework (MOF) Morphology Control by Design K Suresh, AP Kalenak, A Sotuyo, AJ Matzger Chemistry–A European Journal 28 (18), e202200334, 2022 | 30 | 2022 |
| Color polymorphs of aldose reductase inhibitor epalrestat: configurational, conformational and synthon differences B Swapna, K Suresh, A Nangia Chemical communications 52 (21), 4037-4040, 2016 | 28 | 2016 |
Ashwini NangiaProfessor of ChemistryVerified email at uohyd.ac.in
